Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Low-Level Light Therapy (LLLT) is a safe and effective method for skin rejuvenation, acne treatment, wound healing, body contouring, and hair growth, but more well-designed trials are needed for confirmation.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

The HPTLC method is effective and accurate for measuring linoleic and oleanolic acid in Eclipta alba.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Tattooing guidelines focus on safety, hygiene, and following rules.

LLLT is a safe, promising hair loss treatment, but more research needed.

The Itpr3 gene causes a specific hair pattern in mice.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Aloe vera and lime shampoo effectively reduces hair loss and improves scalp cleanliness.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Low-level Laser Therapy may help reduce inflammation, pain, and aid healing, but more research is needed to confirm its effectiveness and establish standard treatment guidelines.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Low-level light therapy with a helmet device can increase hair density and improve scalp appearance.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Erlotinib can cause hair loss and texture changes.

Lime extract can be used to make a stable hair tonic with beneficial compounds.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Low-level laser therapy can stimulate hair growth and increase hair density, making it a promising treatment for hair loss.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.